HQ Settles Baxter's Dispute Over Arrhythmia Drug Generic
HQ Specialty Pharma Corp. resolved Baxter Healthcare Corp.'s suit over a generic version of the antiarrhythmic drug Brevibloc, after a New Jersey federal judge allowed allegations that HQ misappropriated trade secrets,...To view the full article, register now.
Already a subscriber? Click here to view full article